In a filing, Viking Therapeutics Inc revealed its President & CEO Lian Brian unloaded Company’s shares for reported $8.31 million on Jan 06 ’25. In the deal valued at $42.75 per share,194,490 shares were sold. As a result of this transaction, Lian Brian now holds 2,366,570 shares worth roughly $69.1 million.
Then, Mancini Marianna sold 54,215 shares, generating $2,317,599 in total proceeds. Upon selling the shares at $42.75, the Chief Operating Officer now owns 374,134 shares.
Before that, ZANTE GREG sold 50,309 shares. Viking Therapeutics Inc shares valued at $2,150,595 were divested by the Chief Financial Officer at a price of $42.75 per share. As a result of the transaction, ZANTE GREG now holds 165,259 shares, worth roughly $4.83 million.
Scotiabank initiated its Viking Therapeutics Inc [VKTX] rating to a Sector outperform in a research note published on February 13, 2025; the price target was $102. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early February with a ‘”a Neutral”‘ rating. Piper Sandler began covering VKTX with “an Overweight” recommendation on December 02, 2024. B. Riley Securities started covering the stock on November 22, 2024. It rated VKTX as “a Buy”.
Price Performance Review of VKTX
On Friday, Viking Therapeutics Inc [NASDAQ:VKTX] saw its stock fall -14.29% to $29.20. Over the last five days, the stock has lost -4.20%. Viking Therapeutics Inc shares have fallen nearly -27.44% since the year began. Nevertheless, the stocks have fallen -17.00% over the past one year. While a 52-week high of $99.41 was reached on 01/06/25, a 52-week low of $28.64 was recorded on 02/13/25. SMA at 50 days reached $36.97, while 200 days put it at $54.26.
Levels Of Support And Resistance For VKTX Stock
The 24-hour chart illustrates a support level at 27.44, which if violated will result in even more drops to 25.68. On the upside, there is a resistance level at 32.54. A further resistance level may holdings at 35.87. The Relative Strength Index (RSI) on the 14-day chart is 39.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.51, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.77%. Stochastics %K at 42.00% indicates the stock is a holding.
The most recent change occurred on November 04, 2024 when H.C. Wainwright resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $102.
